- Home
- CURI vs PEPG Comparison
CURI vs PEPG Comparison
Compare CURI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- PEPG
- Stock Information
- Founded
- CURI N/A
- PEPG 2018
- Country
- CURI United States
- PEPG United States
- Employees
- CURI N/A
- PEPG N/A
- Industry
- CURI Movies/Entertainment
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- PEPG Health Care
- Exchange
- CURI Nasdaq
- PEPG Nasdaq
- Market Cap
- CURI 264.7M
- PEPG 317.6M
- IPO Year
- CURI N/A
- PEPG 2022
- Fundamental
- Price
- CURI $4.88
- PEPG $4.73
- Analyst Decision
- CURI Strong Buy
- PEPG Strong Buy
- Analyst Count
- CURI 3
- PEPG 6
- Target Price
- CURI $6.00
- PEPG $8.17
- AVG Volume (30 Days)
- CURI 521.1K
- PEPG 9.6M
- Earning Date
- CURI 11-05-2025
- PEPG 11-06-2025
- Dividend Yield
- CURI 6.64%
- PEPG N/A
- EPS Growth
- CURI N/A
- PEPG N/A
- EPS
- CURI N/A
- PEPG N/A
- Revenue
- CURI $60,840,000.00
- PEPG N/A
- Revenue This Year
- CURI $36.83
- PEPG N/A
- Revenue Next Year
- CURI $9.44
- PEPG N/A
- P/E Ratio
- CURI N/A
- PEPG N/A
- Revenue Growth
- CURI 11.02
- PEPG N/A
- 52 Week Low
- CURI $1.47
- PEPG $0.88
- 52 Week High
- CURI $7.15
- PEPG $9.19
- Technical
- Relative Strength Index (RSI)
- CURI 47.23
- PEPG 64.72
- Support Level
- CURI $4.68
- PEPG $4.40
- Resistance Level
- CURI $5.38
- PEPG $5.20
- Average True Range (ATR)
- CURI 0.28
- PEPG 0.54
- MACD
- CURI -0.07
- PEPG -0.07
- Stochastic Oscillator
- CURI 25.58
- PEPG 19.15
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.